![](/imager/uploads/Blog-posts/Davos-24/57345/53467978218_113a67c07a_o_df28e805de22c5499e9444fb93610cd0.webp)
![](/imager/uploads/Companies/Ginkgo-Bioworks/44299/Gingko-1219_6439e647a38ed5b4d852739476ebaac9.webp)
First Investment: 2014
EXIT - NYSE: DNA
The solutions to many of the hardest problems in agriculture, nutrition, pharmaceuticals, energy production, and chemical and material processing lie in synthetic biology. Ginkgo runs biological foundries where automation, machine learning, and analytics work in synchrony to help partners scale up the engineering and manufacture of novel enzymes, proteins, small molecules, and microbial strains.
News & Insights
![](/imager/uploads/Blog-posts/Davos-24/57345/53467978218_113a67c07a_o_df28e805de22c5499e9444fb93610cd0.webp)
Thoughts
Explore Companies
![](/imager/uploads/logos/58681/Avicenna_logo_black_117378e58441a39758ec294c229f7090.webp)
Avicenna Biosciences
Using AI to speed through the last mile of drug discovery
![](/imager/uploads/logos/58643/latus-logo-copy_117378e58441a39758ec294c229f7090.webp)
![](/imager/uploads/Companies/Latus/58650/Latus-lab_6439e647a38ed5b4d852739476ebaac9.webp)
Latus Bio
Finding precisely tuned viral vectors for gene therapy in CNS disorders
![](/imager/uploads/logos/57002/radionetics-logo_black_117378e58441a39758ec294c229f7090.webp)
![](/imager/uploads/Companies/Radionetics/57003/Radionetics_6439e647a38ed5b4d852739476ebaac9.webp)
Radionetics Oncology
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors
![](/imager/uploads/logos/55895/DVLP-logo-black_117378e58441a39758ec294c229f7090.webp)
DVLP Medicines
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing